Since semaglutide further slows gastric emptying as part of its mechanism of action, patients with pre-existing gastroparesis may experience worsening of symptoms including nausea, vomiting, bloating, and abdominal discomfort
General Risks of Using Unapproved Peptides Contamination and Purity Issues: Without FDA oversight, products may contain impurities, incorrect dosages, or harmful additives
Injection technique matters for consistent absorption
Each 10 mg vial is supplied exclusively for laboratory and pre-clinical research into cellular signalling and tissue repair pathways
No doselimiting toxicities or serious adverse events directly attributed to SS31 in published trials [4] [5]
These abnormally large red blood cells, known as megaloblasts, simply can't carry oxygen as efficiently as healthy, normal-sized ones